ADDISON, TEXAS- The Solenic team exhibited at the 2023 Annual Meeting of the American Association of Hip and Knee Surgeons (AAHKS). AAHKS brings together experienced Hip and Knee replacement surgeons and their industry partners to discuss scientific topics such as implant design, outcomes, surgical techniques, and complications of primary and revision total joint arthroplasty. Solenic Medical showcased in the first public unveiling the first generation of their non-invasive breakthrough device (SOLA2) aimed at treating infections in metal implants. Clinicians who attended were very interested in Solenic's technology, welcoming an innovative new solution as a possible way to treat painful prosthetic joint infections (PJIs). Almost two million total knee and hip replacements are performed in the United States each year, with these operations expected to increase by 637% and 174%, respectively, by 2030. One of the most serious complications in the field of arthroplasty is prosthetic joint infection. PJI is currently treated with a two-stage revision requiring two additional surgeries and weeks of antibiotic treatment. While the two-stage revision procedure can be effective, it has a high failure rate, causes significant morbidity in high-risk patients, has a negative impact on quality of life, and is very expensive. The estimated total annual cost of treating patients with PJIs in the United States in 2024 in estimated at $2 billion, representing a significant cost to the healthcare system.
The presence of biofilm, a thin film produced by bacteria that forms a protective shield around the joint and impairs the effectiveness of both antibiotics and the immune system, is a major impediment to effective treatment of PJI. Many medical implants that are used every day, like catheters, mechanical heart valves, intrauterine devices, and prosthetic joints, have been linked to infections. The inability to eliminate biofilm is the primary reason why surgical implant replacement remains the standard of care for the treatment of PJI.
The unveiling of the SOLA2 system marked a milestone for Solenic’s inventors, Rajiv Chopra, PhD, and David Greenburg, MD, as they saw their dream of creating this device come true.
About Solenic Medical, Inc.
Solenic Medical, Inc. is a medical device company founded to develop and commercialize a method for treating prosthetic joint infections (PJI). Solenic will leverage the unique properties of alternating magnetic fields (AMF) generated from external coils to eradicate biofilm on the surface of medical implants. This non-invasive treatment addresses a major complication of various surgeries, such as knee and hip replacements, as well as in trauma related implants such as plates and rods. This is particularly important given an aging population and the rapid increase in the number of these procedures being performed every year. For more information, please visit www.solenic.com